Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNT Esophagus
NCT07603375Phase 2Recruiting
- Sponsor
- Duke University
- Start
- Oct 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, oxaliplatin, docetaxel in esophageal adenocarcinoma (EAC), sponsored by Duke University. Started Oct 2026; status: recruiting.
02
Drugs
fluorouracilfolinic acidoxaliplatindocetaxel
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT07603375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07603375.